BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
SPLS
PIMCO US Stocks PLUS Active Bond Exchange Traded Fund
There isn't enough reported data to score SPLS yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SPLS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SPLS's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SPLS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
SPLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 84x | $54.42 | -0.5% |
| Current | 84x | $54.70 | — |
| Fair | 85x | $55.09 | +0.7% |
| Expensive | 85x | $55.47 | +1.4% |
Historical ranges are pointers, not guarantees.
SPLS has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
SPLS Forward outlook
There aren't enough analyst estimates for SPLS to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus SPLS down 21%.
SPLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2014 | $0.82 | +$1.11 |
| Q2 2014 | $0.85 | +$1.12 |
| Q1 2014 | $0.96 | +$1.22 |
| Q4 2013 | $0.75 | +2400% |
| Q3 2013 | -$0.29 | -122% |
| Q2 2013 | -$0.27 | -119% |
| Q1 2013 | -$0.26 | -118% |
| Q4 2012 | $0.03 | -98% |
SPLS's earnings per share have fallen from their peak: $0.65 over the past year, against $1.41 in early 2012.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 18% for SPLS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
SPLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2017 | $3.9B | -18% |
| Q2 2017 | $4.1B | -19% |
| Q1 2017 | $3B | -42% |
| Q3 2016 | $4.8B | -3.7% |
| Q2 2016 | $5.1B | -3.1% |
| Q1 2016 | $5.3B | -6.9% |
| Q3 2015 | $4.9B | -5.4% |
| Q2 2015 | $5.3B | -6.9% |
SPLS's revenue has slid since its 2011 peak: $3.9B last quarter, down 18% from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with SPLS at up 31%.
SPLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2017 | -$31M | +$314M |
| Q2 2017 | $221M | -4.7% |
| Q1 2017 | $207M | +90% |
| Q3 2016 | -$345M | -$267M |
| Q2 2016 | $232M | -3.3% |
| Q1 2016 | $109M | +$134M |
| Q3 2015 | -$78M | +$40M |
| Q2 2015 | $240M | -23% |
SPLS's free cash flow was $982M over the past year, against −$82M the year before. Free cash flow isn't a meaningful measure for financial services companies like SPLS.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SPLS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SPLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +1M shares |
| 1 year | +1.7% | +11M shares |
| 3 years | -0.1% | -442K shares |
| 5 years | -6.5% | -46M shares |
| Available history | -10% | -72.9M shares |
SPLS has 658M diluted shares, up 1.7% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SPLS Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SPLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.6 | Neutral |
| Stochastic | 31.7 | Neutral |
SPLS's weekly RSI is 67 (neutral) and its Stochastic is 32 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over SPLS on valuation relative to its sector.
SPLS PE vs Financial Services Sector
| Metric | SPLS | Sector median | Relative |
|---|---|---|---|
| PE | 84x | 13x | 543% above |
SPLS is trading at 84x earnings, a 543% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
SPLS has stronger trend alignment. BAC is above 1 of 5 weekly averages versus SPLS above 2 of 4.
SPLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.9 | 0.4% below |
| 20 week MA | $55.0 | 0.5% below |
| 50 week MA | $39.0 | 40% above |
| 100 week MA | $24.0 | 128% above |
SPLS has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 128% above its 100-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
SPLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2016 | $9.62 | $9.22 | -4.2% |
| 2017 | $9.22 | $10.3 | +11% |
| 2026 YTD | $10.3 | $54.7 | +434% |
SPLS has the edge over BAC on returns for 2026, with the stronger performance.